The incidence of Cervical Caner in women can be reduced by one third by the diagnostics tests related to the Human Papilloma Virus (HPV) as the experts have suggested.
Addressing at the the first Indian Cancer Congress (ICC) that concludes Sunday at Kempinski Ambience Hotel, Expert Zoya Brar, co-founder and managing director of Core Diagnostics, a high-end clinical laboratory said that cervical cancer is the most frequent cancer among Indian women and there are approximately 132,000 cases of cervical cancer diagnosed annually in India.
She further added, “More women in India die from cervical cancer than in any other country. The deaths from this preventable disease will rise unless awareness in women increases and elevates the need for a more robust screening paradigm for cervical cancer.”
Brar said she was alarmed at the level of ignorance about cervical cancer during her interactions at a camp organised by Core Diagnostics in Punjab in September.
“Almost one third of cervical cancer can be prevented if HPV testing is used as primary screening test instead of the cytology test.”
The four-day sponsored by Core Diagnostics is being hosted by the Association of Radio Oncologists of India (AROI), the Indian Association of Surgical Oncology (IASO), the Indian Society of Medical and Pediatric Oncology (ISMPO), the Indian Society of Oncology (ISO), and the Oncology Forum.
Over 250 expert speakers and some 5,000 delegates are attending the conference which is expected to act as a catalyst for further research, treatment and dissemination of knowledge in the field of cancer.
(With inputs from IANS)